Ludovica Jona is a freelance journalist and a communication expert based in Rome.

She has a degree in Political Science and a specialisation in International Relations and Multimedia communication at the Fondazione Lelio Basso Journalism School. Member of the Italian Journalists Association since 2008, she worked for different media outlets as Agi, Rainews, L'Unità, E Polis, Left, Altreconomia and Redattore Sociale. She also worked as a media officer for international ngos as Oxfam. In 2014 she wrote the book "Train Stations: how to restore a heritage", a reportage from 50 abandoned train stations which are now used by local associations for social, cultural and touristic projects.

She is the author of the documentary "Mohamed and the Fisherman" and broadcasten by different European tv channels (RaiStoria in Italy, Yle in Finland, SF-DRS in Switzerland) and selected in various film festivals. In 2011 she produced for the national TV channel Rainews the 23-minute video-reportage “Terminal Rifugiati”, which explores the Italian "business on refugees" issue and talks of various cooperatives, later involved in the public inquiry "Mafia Capitale" launched by the Italian magistrature in 2014.

She speaks English, Spanish and French and has a special interest in data journalism.

Ludovica Jona

Basic information

Ludovica Jona
Investigative journalist / video maker

Supported projects

The Business of Madness

  • Equality
  • Social affairs

MADRID/TRIESTE - The cross-border investigation is shedding light on how deinstitutionalisation is taking place in 5 regions of 4 different member states: Spain, Italy, Belgium and The Netherlands. Many people in mental institutions are subject to neglect and abuse of human rights, reflected in high mortality rates.

Marco Cavallo

The Gold Chain

  • Environment
  • Exploitation

In 2022, Brazil has exported for nearly 5 billion dollars of gold worldwide. The intermediary sellers operate in a near total secrecy. What are the routes gold from Pará state travels the world?

The Logging Business

  • Energy

The price of energy from woody biomass.

Behind The Pledge - How EU money is spent for Covid19 drugs

  • Healthcare
  • Industry

BRUSSELS - How did we come to pay gold for a drug whose effectiveness has not been proven? This is the story of Remdesivir, a drug developed by the American company Gilead Sciences with large public funds to combat Ebola, and in July approved by the European Medicines Agency with "conditional authorisation" as the first antiviral against Covid 19.